Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma...
books.google.de
259 Marc-Eric Halatsch and Georg Karpel-Massler Enhanced Glioma Chemosensitivity Rahima Patel, Leroy Shervington, and Amal ...
Tumors of the Central Nervous System: Primary and Secondarybooks.google.com › books
books.google.de
Dysregulated HER1/EGFR signaling. Chapter. 8. Erlotinib in Glioblastoma – A Current Clinical Perspective Georg Karpel-Massler and Marc-Eric Halatsch.
Topics in Anti-Cancer Research: Volume: 2google.co.uk
books.google.co.uk
... the Anticancer Activity of Erlotinib in Glioblastoma Georg Karpel-Massler*, Christian R. Wirtz and Marc-Eric Halatsch Department of Neurosurgery, ...
Erlotinib in Glioblastoma - A Current Clinical PerspectiveGoogle
books.google.com
Georg Karpel-Massler. IntechOpen, Medicine · 0 Reviews. Reviews aren't verified, but Google checks for and removes fake content when it's identified. › about
F RECURRENT GLIOBLASTOMA: INITIAL EXPERIENCES …
virtualtrials.com
VerkkoMarc-Eric Halatsch, MD, PhD (1), Michael E. Salacz, MD (2), Bernd Schmitz, MD, PhD (1), Georg Karpel-Massler, MD, PhD (1), Tim Heiland, MD (1), Tobias Kreß, MD (1), …
A conceptually new treatment approach for relapsed glioblastoma ...
glioblastome.net
VerkkoEfferth9, Daniele Focosi10, Seyed H. Ghaffari11, Georg Karpel-Massler12, Kirsi Ketola 13 , Alireza Khoshnevisan 14 , Daniel Keizman 15 , Nicolas Magné 16 , Christine Marosi …
The Molecular Basis of Resistance to the Antiproliferative InTech
cdn.intechweb.org
to the Antiproliferative Effect of EGFR. Inhibition in Human Glioblastoma. Multiforme Cell Lines. Georg Karpel-Massler and Marc-Eric Halatsch.
Synthese und Funktionalisierung von bioaktiven 7 …
www.albrecht.oc.rwth-aachen.de
VerkkoAdditionally, selected azaindole derivates were tested by Prof. Dr. Georg Karpel-Massler, UK Ulm, to determine their anti-neoplastic activity towards glioblastoma cells. Among …
A critical evaluation of PI3K inhibition in Glioblastoma and ...BioMed Central
molcelltherapies.biomedcentral.com
von MA Westhoff · · Zitiert von: 57 — A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy. Mike-Andrew Westhoff,; Georg Karpel-Massler, ... › ...
Interview With Dr. Marc-Eric Halatsch | InTechOpen Blog
intechweb.wordpress.com
Together with Dr. Georg Karpel-Massler, Dr. Halatsch is the co-author of the chapter titled “The Molecular Basis of Resistance to the Antiproliferative Effect of EGFR Inhibition in Human Glioblastoma Multiforme Cell Lines“, taken from InTech's recently published book “Brain Tumours-Current and Emerging ...
Alle Infos zum Namen "Georg Karpel-Massler"
Erlotinib in Glioblastoma - Lost in Translation? | Bentham Sciencewww.eurekaselect.com › article › erlotinib-glioblast...
www.eurekaselect.com
Erlotinib in Glioblastoma - Lost in Translation? Author(s): Georg Karpel-Massler, M. Andrew Westhoff, Richard E. Kast, Christian Rainer Wirtz, Marc-Eric Halatsch ...
Artesunate Enhances the Antiproliferative Effect of Temozolomide on...
www.eurekaselect.com
As chemotherapy with temozolomide is far from providing satisfactory clinical outcomes for patients with glioblastoma, more
efficient drugs and drug combi
Artesunate Enhances the Antiproliferative Effect of ...intef.es
procomun.intef.es
Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines. Author(s): Georg Karpel-Massler, Mike-Andrew ... › reverse
Cancers | Free Full-Text | Epidermal to Mesenchymal Transition and...
www.mdpi.com
Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma. Andrej Pala 1. , Georg Karpel-Massler 1.
Ehu Sigma-Aldrich
www.sigmaaldrich.com
Results of 9 — Georg Karpel-Massler et al. Oncotarget, 6(34), ( ). Glioblastoma is the most frequent ... › e...
Erlotinib in Glioblastoma - Lost in Translation?Bentham Science
www.eurekaselect.com
Author(s): Georg Karpel-Massler, M. Andrew Westhoff, Richard E. Kast, Christian Rainer Wirtz and Marc-Eric Halatsch. Volume 11, Issue 8, › node
Glioblastoma: Karpel-Massler, G - Expertscape.com
www.expertscape.com
Best hospitals and doctors for Glioblastoma - focus on G Karpel-Massler
Siegelin & Karpel-Massler - Metabolic Reprogramming Of Glioblastoma...
player.fm
Full text - http://bit.ly/1TYK5Rg Oncotarget | Interview with Dr. Markus D. Siegelin & Dr. Georg Karpel-Massler - Department of Pathology & Cell ...
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the...
www.dovepress.com
· ... MCP-1 with the MTZ Regimen Michael E Salacz,1,2 Richard E Kast,3 Najmaldin Saki,4 Ansgar Brüning,5 Georg Karpel-Massler,6 Marc-Eric ...
Erlotinib in Glioblastoma – A Current Clinical Perspective |...
www.intechopen.com
Erlotinib in Glioblastoma – A Current Clinical Perspective | InTechOpen, Published on: Authors: Georg Karpel-Massler and Marc-Eric Halatsch.
Oncotarget | CUSP9* treatment protocol for recurrent glioblastoma:...
www.oncotarget.com
Oncotarget | https://doi.org oncotarget Richard E. Kast, Georg Karpel-Massler, Marc-Eric Halatsch
Inhibition of deubiquitinases primes glioblastoma cells to apoptosis...
www.oncotarget.com
https://doi.org oncotarget Georg Karpel-Massler, Matei A. Banu, Chang Shu, Marc-Eric Halatsch, Mike-Andrew Westhoff, Jeffrey N. Bruce, Peter...
A conceptually new treatment approach for relapsed glioblastoma:...
www.oncotarget.com
https://doi.org oncotarget.969 Richard E. Kast, John A. Boockvar, Ansgar Brüning, Francesco Cappello, Wen-Wei Chang, Boris Cvek, Q Ping Dou, Alfonso...
Verwandte Suchanfragen zu Georg Karpel-Massler
| Rainer Wirtz Christian Rainer Wirtz Marc-Eric Halatsch | Mike-Andrew Westhoff Bernd Schmitz Eric Halatsch | Oliver Brühl Rebecca Kassubek Annika Dwucet |
Personen Vorname "Georg" (36045) Name "Karpel-Massler" (1) |
sortiert nach Relevanz / Datum